An independent committee of vaccine experts just gave a unanimous recommendation to the Food and Drug Administration that they give full authorization for Johnson & Johnson's single-shot COVID-19 vaccine for people 18 years and older, according to a new document posted on the FDA's official website.
With this news, the latest vaccine against the virus is on track for approval as soon as Saturday.
Johnson & Johnson COVID-19 vaccine approved by independent FDA committee
Today, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) gathered to discuss data on the latest clinical trials of Johnson & Johnson's single-shot COVID-19 vaccine, which underwent FDA evaluation in the last several weeks.
The FDA's initial analysis suggested the vaccine was safe, with an 85% effectiveness rating against serious cases of COVID-19 illness around the world. As of writing, no one who received the Johnson & Johnson vaccine has been hospitalized or died from the virus.
This is breaking news about the impending authorization by the FDA of Johnson & Johnson's single-shot COVID-19 vaccine, so be sure to check-in with us for more updates.